Praxis Precision Medicines, Inc.
Praxis Precision Medicines, Inc. (PRAX) Stock Forecast & Analyst Price Target
Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.
prax · stock forecast · 16 analysts (3M) · FMP · updated Jun 8, 2026
Analyst Rating & Consensus
Based on 16 Wall Street analysts in the past 3 months
Buy
16 analysts
consensus
Rating Breakdown
12-Month Price Target
High
$1201
Consensus
$596
+137.0% upside
Low
$162
Median: $563 · Last Close: $251.40
12-Month Price Target Forecast
Historical closing prices + analyst 12-month price target forecast cone
Consensus Target
$595.93
137.0% upside
High Target
$1201
377.7%
Low Target
$162
-35.6%
Current Price
$251.40
as of today
Based on analyst price targets, the PRAX stock price prediction for the next 12 months ranges from $162 to $1201. The consensus PRAX price forecast of $595.93 implies 137.0% upside from the current price of $251.40.
Short-Term Price Prediction
Algorithmically generated · Updated daily
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $238.83 | ↓ 5.00% |
1-day model range: $236.54–$241.12. Peak: $241.12 (-5.00%).
Long-Term Stock Price Prediction
Stock Forecast Based on Technical Analysis
14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency
Market Sentiment
BEARISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · PRAX · Jun 8, 2026
Latest Analyst Ratings & Upgrades
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-06-02 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2026-06-02 | Wedbush | Maintains | Underperform→Underperform |
| 2026-06-02 | Deutsche Bank | Maintains | Buy→Buy |
| 2026-06-02 | Truist Securities | Maintains | Buy→Buy |
| 2026-06-02 | Oppenheimer | Maintains | Outperform→Outperform |
| 2026-06-02 | BTIG | Maintains | Buy→Buy |
| 2026-06-02 | Baird | Maintains | Outperform→Outperform |
| 2026-05-26 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2026-05-20 | BTIG | Maintains | Buy→Buy |
| 2026-05-13 | Truist Securities | Maintains | Buy→Buy |
Wall Street analysts have recently issued updated ratings on Praxis Precision Medicines, Inc. (PRAX) stock. Of the recent 111 rating actions, 0 were upgrades and 2 were downgrades. 16 analysts currently cover PRAX.
Analyst Recommendation Trends
PRAX analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 12 to 6 per month.
Financial Forecast: EPS & Revenue Estimates
Revenue This Year
$5M
↓ 99.6% YoY
Revenue Next Year
$320M
↑ 6960.8% YoY
EPS This Year
$-15.22
EPS Next Year
$-10.92
↓ 28.2% YoY
EPS ForecastReported vs Estimated
Analysts forecast PRAX EPS of $-15.22 for the current fiscal year, based on estimates from 13 analysts. The PRAX revenue forecast is $5M for the current year. These are analyst consensus estimates via FMP / S&P Global.
About Forecast & Price Prediction
The PRAX stock forecast is supported by two independent data sources: analyst consensus ratings from 16 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus PRAX price target is $595.93 (+137.0% upside), with an analyst consensus of Buy.
The PRAX short-term stock prediction for tomorrow is $238.83 (-5.00%).
Praxis Precision Medicines, Inc. trades on NASDAQ under the ticker PRAX. The PRAX stock outlook for 2027 is broadly positive, supported by a Buy consensus among 75% of covering analysts.
Frequently asked questions
PRAX forecast · 8 questionsAccording to 16 Wall Street analysts, the average 12-month PRAX price target is $595.93, with a high forecast of $1201.00 and a low of $162.00. The median price target is shown in the chart above when available. This implies +137.0% potential upside from the current price of $251.40.
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.